A study by Janssens et al., substantiating this bimodal activity of beta hCG in breast carcinoma was conducted in 1998 and 1999 in two phases, where in phase I the inhibitory effects of recombinant hCG (rhCG) was tested on primary breast cancer. Here, RHCG is linked to breast cancer.